Безопасен ли myristoyl octapeptide-31 при беременности?

Related ingredients

Frequently asked questions

Безопасен ли myristoyl octapeptide-31 при беременности?

No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR safety assessment flagging reproductive hazard. Peer‑reviewed literature and public databases (PubChem, CosIng) contain no reproductive toxicity or teratogenicity data for myristoyl octapeptide‑31. As an acylated cosmetic peptide with increased lipophilicity vs the parent peptide, topical absorption is plausible but expected to be low for typical cosmetic use (hence exposure = 1). Sources consulted: ECHA Annex VI (no harmonised CLP), CosIng, PubChem, PubMed (no reproductive studies found), CIR (no assessment).

Безопасен ли myristoyl octapeptide-31 при грудном вскармливании?

No data indicating damage to lactation or transfer into breastmilk; no harmonised classification or regulatory safety warnings. By analogy to other topical peptides and given modest dermal absorption potential, low but measurable exposure is assumed during topical use. Same data sources as for pregnancy show no reproductive/lactation concerns.

Безопасен ли myristoyl octapeptide-31 для кожи малыша?

No infant‑specific toxicology or dermal absorption studies identified. Because infant skin (0–3 yr) has higher surface‑area‑to‑bodyweight and a less mature barrier, dermal exposure was conservatively increased by one exposure level versus adults (adult e=1 → baby e=2). No evidence suggests increased inherent reproductive or mechanistic hazard to infants.

Как VeriMom оценивает myristoyl octapeptide-31?

VeriMom оценивает myristoyl octapeptide-31 в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы myristoyl octapeptide-31 при беременности?

См. наш список безопасных альтернатив myristoyl octapeptide-31 с аналогичной функцией и классификацией без известных рисков.